22 May 2013
Keywords: genta, enrolls, first, patients, ph, iii, genasense
Article | 03 September 2007
US drugmaker Genta says that the first patients have been enrolled in the confirmatory Phase III trial of Genasense (oblimersen ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2007
10 September 2007
© 2013 thepharmaletter.com